Future Opportunities With Interchangeable Biosimilars
A panel of experts discuss future opportunities with interchangeable biosimilars from payer and provider perspectives.
Stay updated with breaking news from Payer Perspective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of experts discuss future opportunities with interchangeable biosimilars from payer and provider perspectives.
Experts review best practices around plan design that payers and plan sponsors should address as more interchangeable biosimilars potentially enter the market.
Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.
Kimberly C. Chen DO, MSHLM, and Maia Kayal, MD, MS, review the challenges related to biosimilars from the payer perspective and strategies payers may employ to help improve the uptake of biosimilars.